... you will know which financial news organizations are 'in the pockets' of short interests on Wall St
Agree. The straw that will make or break the camel's back however remains - no surpise - the FDA, and not intending any disrespect to Germany or the oncologists working on CS over there. In this regard one has to wonder if mgmt is focused correctly on what should be its main objective. It's been 3 years since the famous ODAC when the Co. said it would embark on a new ph 3 for OM with the improved filter ... I would've thought after 3 yrs this would have already been undertaken and concluded, but it seems it's still very much in the early stage - why is that, I ask - as they already had and were using the Gen2 filter way back then? And as far as the FDA is concerned now, I wonder to what extent Padzur & Co. is watching or taking interest and note in the work and developments being seen in Germany now - thanks.
Thanks - we need to be reading about these noteworthy interim results and developments in the media - starting with some European news outlets and medical journals - and not only in company p.r announcements. That's when the stock could start to make a comeback. Where are dcth's p.r. advisors? Hopefully doing more now than trolling the message boards.
... or are there some other clinical results the co. is expected to release soon?
Since the last reverse split, only about two years ago, investors' holdings have been devalued I believe by approx 95% - with the 'actual' pre-split price of those shares today equaling about 1.5 cents (pre-split price back then i believe was about .32 cents). Gives the sense that a few years back this was morphed into more of a trade manipulation and shorting vehicle for short-term gain by some. Now I guess the real question is will this be just another 'wash, rinse and repeat' with the second r/s; so if a similar trading pattern and devaluation occurs yet again, the shares will come out equaling what - some fraction of a penny? Hard to watch, but quite a lesson for any newbie or would-be investor to watch and learn.
Look, smart guy, it's only that Chip and Mike for all their years of 'backlog talk' have made a habit of missing quarterly estimates by wide margins on both the bottom and top lines - that's all. Apart from that rather small detail - and the fact that revenues now seem to be going in the wrong direction - I guess you can say that there is some good news to be found 'somewhere else' in the report. That's just great, smart guy. That's kinda like saying that although a MLB team keeps losing more and more games and are in a worsening slump, season after season, that at least they've made a habit of losing with more men on base - well that just great, super.
(that is 'what happened' to the supposed strong moat ... or is it that Nuan is quietly collecting royalties from the aforementioned companies? Thks
I thought it was always said that Nuance, the industry leader in voice recognition, had this vast patent estate in VR and a strong 'moat' surounding it. So why then does it seem all these major companies (Goog, Msft, Amazon, etc.) are able to come in and develop ambitious voice products and operate almost unencumbered in the space? Where is Nuance in this and happened to that strong moat?
Look, the company was only founded in 1969 -- give it some time to show that it can one day reach profitability. There is always future backlog, even though that may just confuse things even more as revenues seem only to keep declining as a result.
Unfortunately that 'is' the only thing that matters. Doesn't seem that Chip and Mike, for all their long-winded talks about rosy outlooks, exciting RFPs and backlog build-up are just not capable of reversing this glaring reality and right the ship ... and after so many years.
Still have a hard time figuring out if there are positive developments expected from the interim and they are expected this quarter then why not wait til then to secure a more favorable deal and price? Seems like a no brainer if you have any interest in maximizing the value of your assets as well as any sense of fiduciary duty to your shareholders (which I presumed is something not merely notional but obligatory).
Aren't these expected soon? Seems with that they could have negotiated for a higher price - and a better deal for both the company and shareholders. Doesn't make sense, if you consider at all basic fiduciary standards and responsiliblity towards shareholders.
I'm not great at math but I guess that means that the .26 now actually equates to less than .02 cents pps -- pre-split price of two years ago? And another reverse split that management may want to effect already, performing let's say under the same scenario, would bring the original pps down further still, to some decimal of .01 cents? Is that right? geez
(anyway, you probably already know that and are likely just hoping to short the stock again in the event of another r/s ... the old trick)
they just did a reverse split only 1-2 years ago. even though the pps has tumbled back all the way down, don't believe they will be allowed to enact another r/s so soon
I think for them it will end badly
Not disageeing with you Akon, just sayin' that after all these years, all the effort and investment, all the epochs and near misses, shifting managements and company sagas, would be nice if at long last DCTH finally achieved something, contributed something